Twitter Facebook LinkedIn YouTube

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) received its first notice of Allowance

Video Platform Video Management Video Solutions Video Player

Lexaria Bioscience Corp has received its first Notice of Allowance for one of its US patent applications from the US Patent and Trademark Office. Lexaria Bioscience, a food sciences company, is focused on the delivery of active compounds that can behave as superfoods through its proprietary infusion technologies.

Additional Information:

Company: Lexaria Bioscience Corp
Website: http://lexariaenergy.com
Stock Symbol: CSE: LXX
Date Published: Jul 13, 2016
Transcript: Available

Video Transcript:

I’m Samantha Deutscher for Investmentpitch media

Lexaria Bioscience Corp (CSE:LXX) (OTCQB:LXRP) has received its first Notice of Allowance for one of its US patent applications from the US Patent and Trademark Office. Lexaria Bioscience, a food sciences company, is focused on the delivery of active compounds that can behave as superfoods through its proprietary infusion technologies.


Management calls this a “watershed event” in its advancement as a bioscience company.

Lexaria Bioscience, a food sciences company, is focused on the delivery of active compounds that can behave as superfoods through its proprietary infusion technologies.

In simple terms, by combining a lipophilic active agent and a taste enhancing oil with the food product, the company’s unique technology allows for more efficient and effective absorption of molecules, while simultaneously masking, and at times even eliminating, inherent strong flavours and odors.

The process is fully explained in a recent interview of Chris Bunka by Tia Borden, which is available for viewing on www.InvestmentPitch.com

The company plans to leverage its IP prowess for various areas of the economy, such as the rapidly evolving cannabinoid sector; the vitamin sector; the NSAID sector; and even the nicotine sector.

The technology is extremely cost effective to implement and is applicable to the widest imaginable spectrum of foods.

The company has a number of additional patent applications currently undergoing review by the US Patent and Trademark Office.

The company uses the technology in its own line of products, such as the ViPova™ CBD-infused hot beverages and Lexaria Energy CBD-infused protein energy bars.

John Docherty, President, stated: “Lexaria believes that anytime and every time it is successful in progressing a patent application into a granted patent, it not only reinforces the validity of its underlying encapsulation technology, but it also opens new areas of potential revenue generation and economic activity. Lexaria’s allowed and pending patent portfolio is both broad and deep and its executives continue to investigate additional new areas of IP that could be symbiotic with that which is already known.”

The company intends to complete a non-brokered private placement of up to US$300,000 through the issuance of up to 5 million units at US$0.06 per unit.

Each unit consists of one share and one warrant, with each warrant is exercisable at US$0.14 for a period of two years.

The shares are trading at CDN$0.13, and with 44.6 million shares outstanding, the company is capitalized at CDN$5.8 million.

For more information, please visit the company’s website www.LexariaEnergy.com, or contact Chris Bunka, Chairman & CEO, at 250-765-6424 or email bossbunka@gmail.com.

I’m Samantha Deutscher for Investmentpitch media